Sign In
Buy KHRNF
$0.00001
+0 (+0%)
At Close: Jul 31, 2026
Khiron Opens First Zerenia™ Clinic in Peru, Prescribing High and Low THC Medical Cannabis Products to Patients
09:00am, Thursday, 10'th Jun 2021
Company launches first Zerenia™ medical cannabis clinic outside of Colombia, exporting proven clinic model via strategic partnership with Lima-based Clinica Montesur Clinica Montesur is a specialize
Khiron receives its largest European medical cannabis shipment to date
09:48am, Tuesday, 08'th Jun 2021
Khiron's largest shipment to date of EU-GMP certified medical cannabis product arrives in Germany Khiron 20/1, a THC-dominant Cannabis flower, becomes second Khiron-branded product to launch in Germa
Khiron Announces Upcoming Investor Events and Grant of Options and Restricted Share Units
06:30pm, Monday, 31'st May 2021
TORONTO, May 31, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core o
Khiron Life Sciences Reports First Quarter 2021 Financial Results
05:00pm, Thursday, 27'th May 2021
Record revenues of $2.8 million in Q1 2021, a 49% increase from the prior year and 13% increase from Q4 2020 Record gross profits (before fair market value adjustments) of $1.1 million, a 171% improve
Khiron Partners with Colombia Cancer League to Deliver 3,000 Medical Cannabis Patient Consultations
10:18am, Tuesday, 25'th May 2021
Khiron and the Colombia Cancer League, together with 21 leading medical institutions in 11 cities throughout Colombia, have co-launched the "Cannabis: Medicine for Your Life" campaign which aims to im
Khiron to Host First Quarter 2021 Conference Call on May 28, 2021
05:30pm, Wednesday, 19'th May 2021
TORONTO, May 19, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated medical cannabis leader with core o
Khiron Life Sciences Reports 2020 Fiscal Year End Results and Provides Corporate Update
06:36pm, Thursday, 29'th Apr 2021
Generated 31% sequential quarter-on-quarter growth in Q4 2020, driven by normalized clinic operations and more than doubling of medical cannabis sales. Benefited from medical cannabis insurance covera
Company has received UK Continuing Professional Development ("CPD") accreditation for its global education platform, Khiron Academy UK medical professionals may now earn CPD credits through Khiron's m
Khiron Expands Product Offering in UK and Increases Patient Access
08:30am, Wednesday, 07'th Apr 2021
Following successful medical cannabis launch in Germany, Khiron 1/14, a high CBD flower is expected to be available in Q2/21 for UK patients Khiron plans to introduce additional cannabis-based medical
Flora Growth Seeks $15 Million In U.S. IPO
07:30pm, Friday, 26'th Mar 2021
Flora Growth Seeks $15 Million In U.S. IPO
Khiron Updates Zerenia™ Expansion Program; Announces Plans to Open Three Additional Satellite Clinics in Colombia by End of Q2
07:30am, Thursday, 18'th Mar 2021
Zerenia™ expansion follows successful start to 2021, with paid prescriptions in first 2.5 months of the year exceeding total 2020 prescriptions in Colombia Satellite clinics proving an effective pat
Khiron Life Sciences Corp. To Present At The Q1 Virtual Investor Summit
08:30am, Thursday, 11'th Mar 2021
TORONTO, March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations
Khiron Becomes First Colombian Medical Cannabis Company to Export Live Cannabis Clones to Europe
07:00am, Thursday, 11'th Mar 2021
Khiron has successfully exported its registered cannabis strains, in the form of live clones, from Colombia to Europe Company is executing on an asset light growth strategy in Europe by working with c
Khiron Announces Grants of Restricted Share Units
08:00pm, Tuesday, 09'th Feb 2021
TORONTO, Feb. 9, 2021 /PRNewswire/ - Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN), (OTCQX: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operati
Blockchain And Cannabis (Podcast Transcript)
07:22am, Sunday, 07'th Feb 2021
In an unpredictable year, blockchain and cannabis have been some of the best investments and two industries most primed for growth. Chris Naprawa, Director and Chairman of the Board at Khiron and Pres
